The Global Health Network, hosted by NDM, proudly announced the official launch of its Middle East North Africa (MENA) Regional Hub, an initiative set to revolutionise health research, education, and practice across the region. The launch event was held at the Canadian University Dubai on the 21st October 2024, and brought together leading experts, policymakers, and academic institutions to chart a path toward a healthier and more resilient future for the MENA region.
On Thursday, Nigeria announced the regulatory approval and launch of the new R21/Matrix-M\u2122 malaria vaccine that will be freely administered to recipients. This marks a significant milestone in the country\u2019s fight against the deadly disease.
The Africa Oxford Initiative is thrilled to welcome its largest-ever cohort of over 70 graduate scholars from countries in Africa to the University of Oxford.
A new study published in Nature Communications has identified a new potential transmission route for H5 highly pathogenic avian influenza viruses (HPAI). Understanding actual \u201cbird flu\u201d rates in humans will help prevent further spillover and a potential new pandemic.
New research from the United Nations Development Programme (UNDP) and the Oxford Poverty and Human Development Initiative (OPHI) has found that poverty rates in conflict-affected nations are almost three times higher than in countries free from conflict.
Researchers at Oxford Population Health and the Uganda Ministry of Health have presented new evidence assessing the effectiveness of the current indicators used by the World Health Organization (WHO) to identify likely cases or communities affected by periportal fibrosis (PPF) as a result of schistosomiasis. The study is published in The Lancet Microbe.
A promising human vaccine candidate against the potentially deadly Rift Valley fever, a mosquito-borne disease affecting countries across Africa, is set to begin Phase II trials in Kenya. This is the most advanced stage of testing a human Rift Valley fever vaccine has reached in an outbreak-prone area to date. A team of scientists at the Nuffield Department of Medicine and the KEMRI-Wellcome Trust Research Programme will lead the $3.7m trial, funded by the Coalition for Epidemic Preparedness Innovations (CEPI).
A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.
A new University-wide network on antimicrobial resistance aims to generate novel research and collaborations to tackle one of the most urgent global health threats.
Luu Phuoc An, a PhD student at NDM\u2019s Oxford University Clinical Research Unit (OUCRU), is dedicated to improving end of life care in Vietnam. Her research explores the complex cultural, emotional, and medical aspects of death and dying in hospital settings.
The MORU-OUCRU Discovery Research Academy (MODRA) recently concluded its inaugural workshop in Bangkok. This intensive five-day programme equipped 15 promising postdoctoral researchers with the skills required to complete a high-quality seed proposal.
Professor Prabhat Jha has been appointed as Nuffield Professor of Population Health and Head of the Nuffield Department of Population Health. He will succeed Professor Sir Rory Collins who has been Head of Department since its inception in 2013.
US adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford\u2019s Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.
A new study which will help inform World Health Organization guidelines for treating children with Plasmodium vivax malaria has found that giving children higher doses of primaquine substantially reduced recurrences of malaria.
Pandemic Preparedness: Why the Humanities and Social Sciences Matter \r\nA recently published article in Frontiers in Public Health outlines the importance of insights from the humanities and social sciences for developing and maintaining preparedness for future pandemics. Here, Sally Frampton explains how this interdisciplinary and collaborative research publication came about.
Timothy Walsh, Director of Biology at the Ineos Oxford Institute for antimicrobial research outlines three priorities that global leaders must consider at the UN High-Level Meeting on AMR held today.
Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.
![\"Key](\"https://www.globalhealth.ox.ac.uk/news/the-global-health-network-mena-regional-hub-officially-launched/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n